Stupp, R., Tosoni, A., Bromberg, J. E. C., Hau, P., Campone, M., Gijtenbeek, J., . . . Brandes, A. A. (2011). Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group. Oxford University Press.
Stile di citazione ChicagoStupp, R., et al. Sagopilone (ZK-EPO, ZK 219477) for Recurrent Glioblastoma. A Phase II Multicenter Trial By the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group. Oxford University Press, 2011.
Citazione MLAStupp, R., et al. Sagopilone (ZK-EPO, ZK 219477) for Recurrent Glioblastoma. A Phase II Multicenter Trial By the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group. Oxford University Press, 2011.